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Long‑term outcomes 
following vehicle trauma related 
acute kidney injury requiring renal 
replacement therapy: a nationwide 
population study
Chieh‑Kai Chan1,2,3, Chun‑Yi Chi2,4, Tai‑Shuan Lai2, Tao‑Min Huang2, Nai‑Kuan Chou5, 
Yi‑Ping Huang5, John R. Prowle7,8,9*, Vin‑Cent Wu2,6* & Yung‑Ming Chen2
Acute kidney injury (AKI) is a frequent complication of traumatic injury; however, long‑term outcomes 
such as mortality and end‑stage kidney disease (ESKD) have been rarely reported in this important 
patient population. We compared the long‑term outcome of vehicle‑traumatic and non‑traumatic 
AKI requiring renal replacement therapy (AKI‑RRT). This nationwide cohort study used data from the 
Taiwan National Health Insurance Research Database. Vehicle‑trauma patients who were suffered 
from vehicle accidents developing AKI‑RRT during hospitalization were identified, and matching 
non‑traumatic AKI‑RRT patients were identified between 2000 and 2010. The incidences of ESKD, 
30‑day, and long‑term mortality were evaluated, and clinical and demographic associations with 
these outcomes were identified using Cox proportional hazards regression models. 546 vehicle‑
traumatic AKI‑RRT patients, median age 47.6 years (interquartile range: 29.0–64.3) and 76.4% 
male, were identified. Compared to non‑traumatic AKI‑RRT, vehicle‑traumatic AKI‑RRT patients 
had longer length of stay in hospital [median (IQR):15 (5–34) days vs. 6 (3–11) days; p < 0.001). 
After propensity matching with non‑traumatic AKI‑RRT cases with similar demographic and clinical 
characteristics. Vehicle‑traumatic AKI‑RRT patients had lower rates of long‑term mortality (adjusted 
hazard ratio (HR), 0.473; 95% CI, 0.392–0.571; p < 0.001), but similar rates of ESKD (HR, 1.166; 95% 
CI, 0.829–1.638; p = 0.377) and short‑term risk of death (HR, 1.134; 95% CI, 0.894–1.438; p = 0.301) as 
non‑traumatic AKI‑RRT patients. In competing risk models that focused on ESKD, vehicle‑traumatic 
AKI‑RRT patients were associated with lower ESKD rates (HR, 0.552; 95% CI, 0.325–0.937; p = 0.028) 
than non‑traumatic AKI‑RRT patients. Despite severe injuries, vehicle‑traumatic AKI‑RRT patients had 
better long‑term survival than non‑traumatic AKI‑RRT patients, but a similar risk of ESKD. Our results 
provide a better understanding of long‑term outcomes after vehicle‑traumatic AKI‑RRT.
Background. Acute kidney injury (AKI) has been studied in a wide range of populations and has been 
consistently associated with increased risk of future morbidity and  mortality1,2. The in-hospital mortality associ-
ated with AKI ranges from 9.1% to 21.9% in the United  States3, and amounts to as high as 62% in the critical 
care setting in patients requiring renal replacement therapy (RRT)4,5. As AKI is a clinical syndrome it treatment 
should be tailored to its underlying etiology. While considerable data exist on the epidemiology, outcomes and 
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suggested management of AKI in settings such as sepsis or nephrotoxin exposure, comparatively less data is 
available to guide clinicians on the clinical course of AKI after major trauma.
Trauma is a leading cause of hospitalization worldwide, which mainly affects a young and previously healthy 
population both in the developed and developing world. The incidence of AKI among major traumatic inju-
ries has been reported to be 6.0–36.8%6,7, and traumatic AKI has been associated with a mortality rate of 
14.9–57.0%7–10. Overall around 5% of trauma patients admitted to the intensive care unit (ICU) require RRT 
10. In a recent systematic review the pooled incidence of AKI after trauma was 20.4% with an associated 3.6-
fold increase in the relative risk of death, commonly reported associations of AKI after trauma include older 
age, higher severity of injury, volume of blood transfusion, abdominal site of injury and presence of comorbid 
disease including diabetes  mellitus11. Prior studies of traumatic AKI-RRT have focused mainly on short-term 
 outcomes12,13 and detailed comparisons of outcomes between traumatic-AKI and AKI of differing etiologies 
that have not been made.
Given the paucity of studies concerning traumatic AKI-RRT, we sought to describe its epidemiology and 
associated short and long-term outcomes in a large epidemiological database.
Results
Temporal change in in‑hospital mortality. Among 123,470 hospitalized AKI-RRT patients in the past 
decade, we identified 546 vehicle-traumatic AKI-RRT patients who survived to index discharge (Fig. 1). The 
annual number of trauma cases decreased gradually; however, the proportions of vehicle-traumatic AKI-RRT 
patients tended to increase over time, especially in the elderly group (aged ≥ 65 years) (Fig. 2). In our cohort, 
young patients (aged ≤ 44 years) were less likely to be admitted because of trauma; however, they had the highest 
incidence of vehicle-traumatic AKI-RRT (Fig. 2) during hospitalization. On the other hand, soft tissue injury 
from trauma had the lowest incidence of AKI-RRT (Fig. 3).
Patient characteristics before and after propensity score matching. Compared to patients with 
other causes of AKI-RRT, vehicle-traumatic AKI-RRT patients were younger [median IQR: 47.6 (29.0–64.3) 
vs. 65.9 (53.7–74.5), p < 0.001) and more of them were male (77.1% vs. 54.2%, p < 0.001). Vehicle-traumatic 
AKI-RRT patients also had a lower rate of cerebrovascular disease, COPD, diabetes, liver disease, and advanced 
chronic kidney disease (CKD) which was defined as the presence of CKD coding and concomitant reimburse-
ment coding of erythropoiesis-stimulating agents without copayment. More pulmonary and cardiac compli-
cations occurred in AKI-RRT patients than non-traumatic AKI-RRT patients during hospitalization. Among 
them, 517 vehicle-traumatic AKI-RRT patients were successfully matched with 1,551 non-traumatic AKI-RRT 
patients (Table 1).
To evaluate the potential etiology of AKI in our cohort (Supplemental Table 1), we collected the data of in-
hospital acute comorbidities, including hypovolemic shock, cardiogenic shock, and severe sepsis which may relate 
to AKI. In addition, we also collected the data of contrast exposure and nephrotoxicity medications exposure 
Vehicle-trauma (N=546) Non-trauma (N=122,924) 
Further propensity score matching 
Follow-up to death or end of the study date on Dec 31, 2010 
Acute dialysis during admission from 2000 to 2010 
                (N=159,557) 
Excluded (N=36,087) 
Age<18 or >100 years (N=2,087) 
Having prior history of dialysis or dialysis access 
creaon (N=27,196) 
Having prior history of kidney transplant (N=525) 
Mortality during hospitalizaon (N=6,279) 
Newly idenfied paents with AKI and renal 
replacement therapy (N=123,470) 
1:3 Matched by propensity scoring
Vehicle-trauma (N=517) Non-trauma (N=1,551) 
Figure 1.  Flow chart of the participants.
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before AKI-RRT after propensity score matching. Non-trauma patients had higher risk of cardiogenic shock 
(17.4% vs. 1.2%, p < 0.001) and nephrotoxicity medications exposure (18.6% vs. 2.9%, p < 0.001).
The overall median (IQR) follow-up duration is 2.65 (0.14–7.04) years. The vehicle-traumatic group follow-
up duration is 3.32 (0.10–8.85) years and the non-traumatic group follow-up duration is 2.49 (0.16–6.39) years.
Outcomes in patients with AKI‑RRT after discharge. After propensity score matching, the follow-
up period was 2.98 years. The 30-day mortality was similar between two groups (18.4% vs. 15.9%, p = 0.207). 
Although the baseline comorbidities and acute medical problems before index hospitalization were similar in 
both groups after matching, vehicle-traumatic AKI-RRT patients had a longer length of stay in hospital [median 
IQR 15 (5–35) vs. 12 (5–28) days, p = 0.007). The long-term incidence of ESKD was similar between groups 
(10.6% vs. 13.4%, p = 0.832) (Table 1).
Annual number of trauma casesa 
Annual rate of AKI-RRT in patients with traumab
Figure 2.  Temporal patterns of annual number of trauma cases (a) and annual rate of vehicle-traumatic 
AKI-RRT (b) stratified by age groups (annual rate of vehicle-traumatic AKI-RRT = annual number of vehicle-
traumatic AKI-RRT/ annual number of trauma cases). (b) p for trend, age ≦ 44: 0.073, 45 < age < 65: 0.183, age ≧ 
65: 0.004).
Annual number of trauma casesa
Annual rate of AKI-RRT in patients with traumab
Figure 3.  Temporal patterns of annual number of trauma cases (a) and annual rate of traumatic AKI-RRT (b) 
stratified by injured body part (annual rate of vehicle-traumatic AKI-RRT = annual number of vehicle-traumatic 
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The risk of developing ESKD (HR, 1.166, p = 0.377) and 30-day mortality after discharge (HR, 1.134, p = 0.301) 
among the vehicle-traumatic AKI-RRT patients relative to non-traumatic AKI-RRT were similar. However, 
vehicle-traumatic AKI-RRT patients had a lower risk of long-term mortality than non-traumatic group (adjust 
HR: 0.473, p < 0.001) (Table 2). In addition, vehicle-traumatic AKI-RRT patients was associated with lower 
ESKD rates (HR, 0.552; 95% CI, 0.325–0.937; p = 0.028) than non-traumatic AKI-RRT patients in multivariable 
competing risk models which set death as a competing risk. Furthermore, this lower mortality rate after vehicle-
traumatic AKI-RRT persisted after adjusting for age, gender and Charlson score Cox proportional analysis 
(p < 0.001) (Fig. 3).
After stratified vehicle-traumatic AKI-RRT patients by injured body part (Supplemental Table 2), the risk of 
developing ESKD and 30-day mortality after discharge among the vehicle-traumatic AKI-RRT patients relative 
to non-traumatic AKI-RRT were similar except for soft tissue injury from trauma which had lower incidence 
of 30-day mortality (HR, 0.714, p = 0.003). Bones (adjust HR: 0.580, p < 0.001) and abdomen injury (adjust HR: 
0.607, p < 0.001) from trauma had lower risk of long-term mortality than non-traumatic group.
Table 1.  Clinical characteristics after propensity score matching (NHIR database). ECMO, extracorporeal 
membrane oxygenation; ESKD, end stage kidney disease; IQR, interquartile range. *Advanced chronic kidney 
disease: presence of CKD coding and concomitant reimbursement coding of erythropoiesis-stimulating agents 
without copayment. **Prolonged mechanical ventilation: the use of mechanical ventilation ≥ 21 days.
Variables








(n = 517) p Value
Gender (Male) 66,595 (54.2%) 421 (77.1%)  < 0.001 1183 (76.3%) 395 (76.4%) 0.952
Age (year) (IQR) 65.9 (53.7–74.5) 47.6 (29.0–64.3)  < 0.001 48.7 (34.2–64.9) 48.7 (31.5–65.3) 0.469
Pre-admission Comorbidities
Charlson comorbidity index 
(IQR) 0 (0–0) 0 (0–1)  < 0.001 0 (0–1) 0 (0–1) 0.075
Myocardial infarction 988 (0.8%) 3 (0.6%) 0.51 10 (0.6%) 3 (0.6%) 0.872
Congestive heart failure 5410 (4.4%) 22 (4.0%) 0.67 80 (5.1%) 22 (4.3%) 0.412
Cerebrovascular disease 9742 (7.9%) 13 (2.4%)  < 0.001 41 (2.6%) 13 (2.5%) 0.874
Dementia 1384 (1.1%) 1 (0.2%) 0.04 6 (0.4%) 1 (0.2%) 0.512
Chronic obstructive pulmonary 
disease 12,042 (9.8%) 30 (5.5%)  < 0.001 90 (5.8%) 30 (5.8%) 0.999
Peptic ulcer disease 12,025 (9.8%) 28 (5.1%)  < 0.001 99 (6.4%) 28 (5.4%) 0.428
Diabetes mellitus 42,643 (34.7%) 77 (14.1%)  < 0.001 209 (13.4%) 77 (14.9%) 0.419
Moderate or severe liver disease 7229 (5.9%) 24 (4.4%) 0.14 91 (5.8%) 24 (4.6%) 0.293
Chronic kidney disease 92,238 (75.0%) 130 (23.8%)  < 0.001 388 (24.9%) 130 (25.2%) 0.953
Advanced chronic kidney 




tion** 10,506 (8.6%) 416 (76.2%)  < 0.001 1184 (76.0%) 387 (74.9%) 0.494
Re-intubation 5989 (4.9%) 228 (41.8%)  < 0.001 688 (44.2%) 217 (42.0%) 0.344
Acute respiratory distress 
syndrome 509 (0.4%) 7 (1.3%) 0.002 35 (2.3%) 7 (1.4%) 0.208
Pleural effusion 376 (0.3%) 3 (0.6%) 0.30 11 (0.7%) 3 (0.6%) 0.753
Chest tube insertion 1041 (0.9%) 111 (20.3%)  < 0.001 247 (15.9%) 90 (17.4%) 0.429
Hemodynamic complications
Hypovolemic shock 668 (0.5%) 12 (2.2%)  < 0.001 32 (2.1%) 10 (1.9%) 0.856
ECMO use 147 (0.1%) 17 (3.1%)  < 0.001 44 (2.8%) 12 (2.3%) 0.532
Main cause of infection
Pneumonia 2346 (1.9%) 5 (0.9%) 0.09 14 (0.9%) 5 (1.0%) 0.894
Urinary tract infection 2984 (2.4%) 4 (0.7%) 0.01 19 (1.2%) 4 (0.8%) 0.397
Severe sepsis 6041 (4.9%) 72 (13.2%)  < 0.001 243 (15.6%) 68 (13.2%) 0.166
Outcomes
Index hospital stay (day) (IQR) 6 (3–11) 15 (5–34)  < 0.001 12 (5–28) 15 (5–35) 0.007
Follow-up duration (year) 
(IQR) 3.32 (0.1–8.85) 2.49 ()
30-day mortality 2490 (2.0%) 99 (18.1%)  < 0.001 248 (15.9%) 95 (18.4%) 0.207
Long-term mortality 73,777 (60.0%) 134 (24.5%)  < 0.001 729 (46.8%) 129 (25.0%)  < 0.001
ESKD 32,445 (26.4%) 45 (8.2%)  < 0.001 208 (13.4%) 55 (10.6%) 0.892
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After stratified AKI-RRT patients by age (Supplemental Table 3), vehicle-traumatic AKI-RRT patients had 
lower risk of long-term mortality in elder (adjust HR: 0.793, p = 0.042) and younger (adjust HR: 0.580, p < 0.001) 
subgroup than non-trauma cohorts. However, vehicle-traumatic AKI-RRT patients had higher incidence of 
30-day mortality in the elder subgroup (adjust HR: 1.441, p = 0.016).
Discussion
Our study is, to our knowledge, the first to describe the short-term and long-term outcomes of vehicle-traumatic 
AKI-RRT patients from a large national database. Our study demonstrated that vehicle-traumatic AKI-RRT 
patients had lower long-term mortality than non-traumatic AKI-RRT patients. However, incident ESKD and 
short-term mortality were similar between vehicle-traumatic and non-traumatic AKI-RRT patients.
The trend of vehicle‑traumatic AKI‑RRT . In an observational study in the United States, the incidence 
of AKI-RRT increased at an average of 10% per year from 2000 to  20099. In the NHIRD, we found that the pro-
portions of patients with AKI-RRT among vehicle-traumatic patients also increased throughout the years. The 
older the patients, the higher annual number of trauma cases was found; however, the oldest vehicle-traumatic 
group had the lowest incidence of AKI-RRT (Fig. 2). These results may indicate that young people had higher 
severity of trauma and the consequent risk of AKI-RRT. There seemed to be no difference in body distribution 
of injury on the incident vehicle-traumatic AKI-RRT except for the lowest incidence of soft tissue injury related 
AKI-RRT.
ESKD and long‑term mortality in patients with vehicle‑traumatic AKI‑RRT . AKI in traumatic 
patients is a common complication and associated with significantly higher 30-day and 1-year mortality than 
traumatic patients without  AKI12. Although trauma-related risk factors for kidney injury (e.g., direct lesions 
to the kidneys, shock, ischemia–reperfusion, rhabdomyolysis, exposure to nephrotoxic substances, abdomi-
nal compartment syndrome, hemorrhagic shock and sepsis), The rate of long term incident ESKD in patients 
after AKI-RRT in our study did not significantly differ vehicle-trauma and non-trauma populations. However, 
compared to non-traumatic AKI-RRT patients, traumatic patients had lower risk of long-term mortality after 
survival in our cohort. The above results may indicate that the etiology of AKI-RRT may be associated with long-
term mortality. On the other hand, the risk of ESKD existed if renal damage happened regardless of trauma or 
non-trauma. If we consider death as a competing risk, vehicle-traumatic AKI-RRT patients were associated with 
lower ESKD rates than non-traumatic AKI-RRT patients, which may indicate that vehicle-traumatic AKI-RRT 
patients had better renal recovery potential. In addition, the vehicle-traumatic AKI-RRT patients with soft tissue 
injuries may have lower severity trauma which may contribute to better 30-day mortality.
The observed decreased long-term mortality and long-term ESKD in vehicle-traumatic AKI-RRT patients 
after 30 days can be related to the overall better health status of these patients before the traumatic injury and that 
perhaps a greater burden of co-morbidity and complications in the more non-traumatic AKI-RRT population 
with greater baseline debility. This cannot be fully addressed with propensity score-matching involving cross-
sectional comorbidity data at the time of or before index admission.
One of the few other studies examining long term-outcomes after traumatic AKI examined 40 soldiers who 
survived traumatic AKI-RRT in that study there was a lower incidence of ESKD (2.5% vs. 10.6%) and a lower 
long-term mortality (2.5% vs. 25%) rate over a median follow-up of 2.7 years than in our  cohort14. These differ-
ences might be attributed to low incidence rates, younger age (26 ± 6 years), and fewer baseline comorbidities 
in the military  study14.
The management of vehicle‑traumatic AKI. Management of AKI should be considered in the context 
of the underlying etiology; for instance, sepsis-associated AKI will focus on source control of infection hemo-
dynamic support and secondary injury  prevention15, while nephrotoxic will focus on identification removal of 
the offending  agent16.
Table 2.  Incidence and risks for outcome of interest in AKI patients with renal replacement therapy during 
hospitalization, between vehicle-traumatic patients and their matches. ESKD, end-stage kidney disease; CI, 
confidence interval. *The multivariable Cox regression model selected covariates from all variables in Table 1 
and cardiogenic shock and exposure to nephrotoxic medications by a stepwise procedure.
Incidence Crude Adjust*
Events Person-years
Incidence rate per 
1000 person-years Events Person-years






Trauma Non-trauma Trauma vs. non-trauma
Long-term ESKD 45 3614.99 12.45 132 11068.44 11.93 1.039(0.741–1.457) 0.825
1.166
(0.829–1.638) 0.377
30-day mortality 95 36.94 2571.74 248 111.68 2220.63 1.154(0.911–1.462) 0.234
1.134
(0.894–1.438) 0.301
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However, the management of traumatic AKI is complicated because it commonly involves multiple risk 
factors for AKI, including direct traumatic injury to the kidneys, hypovolemic shock, ischemia–reperfusion 
injury, exposure to endogenous and exogenous nephrotoxic substances, and secondary infection. Accordingly an 
understanding of the underlying cause of traumatic AKI is required to enable its optimal management. In addi-
tion, we have demonstrated that that traumatic AKI-RRT patients had lower long-term rates of death or ESKD in 
competing risk analsysis compared to non-traumatic AKI-RRT patients; this might indicate that severe traumatic 
AKI has a generally good prognosis justifying aggressive treatment including the use of RRT where indicated.
Follow‑up strategy in patients of AKI‑RRT . AKI-RRT has been shown to be associated with an 
increased incidence of ESKD,  mortality17, coronary  events13,  stroke18, and bone  fracture19 among those who 
survived to hospital discharge. Although guidelines published by kidney disease: improving global outcomes 
(KDIGO) Clinical Practice Guideline recommend that survivors of AKI be followed up by a nephrologist within 
90  days20, reports in the literature suggest only a small proportion of patients after severe AKI are followed-up 
by a nephrologist after survival  discharge21–23. Given their young age, relative lack or comorbidity, and still sig-
nificant risk of developing ESKD, AKI-RRT is a neglected population where focused medical follow-up could 
address the progression of CKD and development of other complications over a long expected lifespan. These 
results further provide the outcome information for patient care and rational health resource allocation.
Limitation. Our study has certain limitations. Firstly, as all observational studies, we could not exclude the 
possibility of residual confounding. To decrease the effect of potential confounding factors, we developed a 3:1 
propensity score. We were able to construct a comparison cohort with balanced covariates between the two 
groups. Second, with some administrative databases, detailed in-hospital parameters, and laboratory results 
were not available in our cohort. Therefore, we could not examine whether classifying patients into different 
severity scoring systems, such as the Injury Severity Score (ISS) and Acute Physiology and Chronic Health 
Evaluation score. The severity of trauma and illness has been found to be associated with  AKI8,24, and thus could 
be potential predictors of clinical outcome. To attenuate the effect of the limitations, we did adjust by Charlson 
comorbidity index (pre-admission comorbidities) and in-hospital acute comorbidities, including pulmonary 
and hemodynamic complications, to evaluate the disease severity of each patient in our database. We further 
stratify our trauma patients based upon injured body regions as proxies to evaluate the traumatic severity. Third, 
we did not analyze the effect of duration and modality of RRT which may be the predictors of disease severity 
and the confounding factors of long-term outcomes in our study. To attenuate the effect of the limitations, we 
did adjust by Charlson comorbidity index (pre-admission comorbidities) and in-hospital acute comorbidities, 
including pulmonary and hemodynamic complications, to evaluate the disease severity of each patient in our 
database.
Conclusion
In our study, we found that the vehicle-traumatic AKI-RRT patients had better long-term survival than non-
traumatic counterparts with AKI-RRT. However, there were similar outcomes of ESKD and short-term mortality. 
Our findings are pertinent to civilian populations with similar demographics and may inform care in real-world 
practice.
Methods
Study design and setting. National Health Insurance registration database (NHIRD). The Taiwan Na-
tional Health Insurance (NHI) program is mandatory and universal, offering comprehensive medical care cover-
age to more than 99% of the country’s population of 23 million people. This nationwide compulsory healthcare 
program that covers outpatient visits, hospital admissions, prescriptions, interventional procedures, disease 
profiles, and vital statuses. Taiwan’s NHI records are regularly inspected, and physicians are subject to statutory 
 regulation13,19,25–28. The National Health Insurance Research Database (NHIRD) thus represents a comprehen-
sive, high-quality record of healthcare episodes provided to the Taiwanese population.
Selection of participants. We enrolled patients aged ≥ 18  years who were admitted because of major 
trauma and developed AKI-RRT during their index admission as recognized by RRT-related procedure codes 
and survived to hospital discharge. All diagnoses, including trauma-related injuries and baseline comorbidi-
ties, were obtained by the codes of International Classification of Diseases, 9th Revision, Clinical Modification 
(ICD-9-CM). Those that were related to vehicle-related accidents, defined as any of ICD-9-CM E-Code E800 
to E844 included in the diagnosis codes, were aggregated to individuals and were enrolled as study  subjects25. 
When more than one accident was encountered by a single person, only the first event was counted for analysis. 
We identified baseline comorbidities from at least three outpatient visits or one inpatient claim within a one-
year antecedent to the index admission with first dialysis. This rule was constructed based on a relatively strict 
criterion and was well validated with good predictive  power13,19,25,26,29.
Dialysis patients who underwent renal transplantation, vascular access creation, or peritoneal-dialysis catheter 
implantation for chronic dialysis and those who had received chronic dialysis prior to the index admissions were 
excluded. To compare the long-term outcomes of interest, we constructed a comparator group of non-traumatic 
AKI-RRT patients matched to vehicle-traumatic AKI-RRT patients in a 3:1 ratio based on age, gender, and 
propensity scores. (Supplemental Table 4).
As all personal information is de-identified in the research database to protect privacy, no informed consent 
was required, and this study was deemed exempt from a full ethical review by the institutional review board of 
the National Taiwan University Hospital (201212021RINC).
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Outcomes. Our primary outcome was long-term all-cause mortality after hospital discharge. The second-
ary outcomes were 30-day all-cause mortality and de novo end-stage kidney disease (ESKD) defined as the 
requirement of dialysis for at least three months after hospital discharge. We used a selection period of 90 days 
to define ESKD because all patients receiving dialysis for more than 90 days in Taiwan can apply to the NHI for 
catastrophic illness registration  cards30. Each patient was monitored from the date of discharge and was censored 
at either death, dialysis, or the end of the study (December 31, 2010), whichever occurred first.
We also stratified trauma patients by injured body part and age to evaluate the outcomes comparing to their 
matches in the subgroup analysis.
Research variables. We recorded the disease severity and patient condition during index hospitalization. 
Disease severity and patient condition are estimated by the ICU procedure and complications with acute pulmo-
nary [prolonged mechanical ventilation (the use of mechanical ventilation ≥ 21 days), re-intubation, acute res-
piratory distress syndrome, pleural effusion, and chest tube insertion], cardiovascular [hemopericardium, hypo-
volemic shock, cardiac arrest, heart block, atrial fibrillation, extracorporeal membrane oxygenation (ECMO) 
and intra-aortic balloon pumping (IABP)] and infectious (pneumonia, urinary tract infection and severe sepsis) 
and other (delirium, stroke and gastrointestinal bleeding)  disorders31.
The Charlson comorbidity  index32 was computed using baseline comorbidities. Additional adjustments in 
these models included control for direct effects from age, gender, and comorbidities that are listed in Table 1.
Analysis. Baseline characteristics were described as the percentages for categorical variables and median 
with interquartile range (IQR) for continuous variables. Differences between the trauma and non-trauma related 
groups were compared by the independent t-test or χ2 test where appropriate.
To estimate each patient’s propensity score for vehicle-traumatic AKI-RRT, we fitted a separate multivari-
able logistic regression model with the factors predicting vehicle trauma as admitting diagnosis in patients with 
AKI-RRT during index  hospitalization33 (further seen in Supplemental Table 4). The caliper distance is 0.25 and 
subjects are matched without replacement in this propensity score matching. The estimated propensity score was 
also added to adjusting the Cox regression model as a single covariate for controlling selection bias. Multivariable 
logistic regression models before and after propensity-scored matching were applied to estimate odds ratio (OR) 
of study outcomes after adjusting all the confounders predicting trauma (Supplemental Table 4).
We evaluated the association of vehicle-traumatic AKI-RRT with the risks of long-term ESKD, 30-day mortal-
ity and long-term mortality among our cohort using Cox regression models with time-dependent covariates. To 
assess multivariate Cox regression models in mortality and ESKD analysis, the relationship between scaled Sch-
oenfeld residuals and time was examined, with no significant evidence for non-proportionality (p value > 0.05), 
therefore we accepted the assumption in the Cox model of constant hazard ratios over time.
The significance levels for entry and stay were set to 0.15 to be conservative. Then, with the aid of substantive 
knowledge, the best candidate final logistic model was identified manually by dropping the covariates with p 
value > 0.05 one at a time until all regression coefficients were significantly different from 0.
All the analyses were conducted with R software, version 2.8.1 (Free Software Foundation, Inc., Boston, MA, 
USA); competing-risk analysis was performed using Stata/MP version 12 (Stata Corporation). A two-sided 
p-value < 0.05 was considered to be statistically significant.
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